Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin
- 27 March 2000
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 25 (7), 751-755
- https://doi.org/10.1038/sj.bmt.1702228
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infectionsBone Marrow Transplantation, 1997
- Community Respiratory Virus Infections in Immunocompromised Patients with CancerAmerican Journal Of Medicine, 1997
- Respiratory Virus Infections in Bone Marrow Transplant Recipients: The European PerspectiveAmerican Journal Of Medicine, 1997
- Respiratory Virus Infections After Marrow Transplant: The Fred Hutchinson Cancer Research Center ExperienceAmerican Journal Of Medicine, 1997
- Community Respiratory Virus Infections Among Hospitalized Adult Bone Marrow Transplant RecipientsClinical Infectious Diseases, 1996
- An Outbreak of Respiratory Syncytial Virus in a Bone Marrow Transplant CenterThe Journal of Infectious Diseases, 1992
- Respiratory Syncytial Virus-Induced Acute Lung Injury in Adult Patients with Bone Marrow TransplantsMedicine, 1989
- Ribavirin Aerosol in the ElderlySocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1988
- RESPIRATORY SYNCYTIAL VIRUS INFECTIONS IN ADULT BONE MARROW TRANSPLANT RECIPIENTSThe Lancet, 1988
- Aerosolized Ribavirin Treatment of Infants with Respiratory Syncytial Viral InfectionThe New England Journal of Medicine, 1983